Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:55:10.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with its HTML markup, replacing the previous clinical trial content. Sponsor and trial-related sections and external links were removed, indicating the page is serving an error state rather than study details.
    Difference
    20%
    Check dated 2026-09-20T20:11:06.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Two NIH grant/contract entries for 2017 and 2023 were added to the study record, expanding the funding metadata. The page revision tag was updated from v3.6.5 to v3.6.6 to reflect a newer version.
    Difference
    0.0%
    Check dated 2026-08-30T17:34:06.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, and the Plain Language Summary section and the older Revision: v3.6.4 have been removed. This reflects an updated version tag and a change in which content is displayed to users.
    Difference
    0.0%
    Check dated 2026-08-09T09:27:46.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The Ukraine location entry in the Locations list was updated to use a different transliteration (Zaporizhzhya) from Zaporizhzhia. The old entry was removed and a new one added.
    Difference
    0.0%
    Check dated 2026-08-01T23:18:14.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, signaling a newer version of the study detail page. This is a metadata change rather than a substantive update to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T18:37:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.